Park Edge Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Park Edge Advisors's MDT Position: Q3 2026 in Review
Park Edge Advisors sold out of Medtronic (MDT) in Q3 2026, closing a stake of 2,990 shares — an estimated $234K sold.
Park Edge Advisors first reported a position in MDT in Q4 2022 and held it in 15 quarters. The position peaked at $470K in Q2 2023. 1,475 funds tracked by Wall St. Rank hold MDT as of Q3 2026.
- Park Edge Advisors reported no remaining Medtronic position as of Q3 2026 after selling out during the quarter.
- Park Edge Advisors sold 2,990 Medtronic shares in Q3 2026, an estimated $234K.
- Park Edge Advisors first reported a position in Medtronic in Q4 2022 and held it in 15 quarters.
- Park Edge Advisors's Medtronic position peaked at $470K in Q2 2023.
- 1,475 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.
Based on Park Edge Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.